Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | GRFS | CRNX | ||
| Company | Turning Point Therapeutics Inc | Grifols S.A. ADR | Crinetics Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 6.49 | 46.09 | ||
| High | 76.01 | 6.49 | 47.15 | ||
| Low | 75.98 | 6.49 | 45.19 | ||
| Last | 76.01 | 6.49 | 45.89 | ||
| Change | +0.52 | -0.03 | +0.35 | ||
| % Change | +0.69% | -0.46% | +0.77% | ||
| Volume | 2,843,300 | 974 | 1,253,800 | ||
| 20-Day Average Volume | 962,475 | 1,128,509 | 1,114,225 | ||
| Previous Close | 75.49 | 6.52 | 46.07 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 6.92 | 45.32 | ||
| 20-Day Raw Stochastic | 100.00% | 40.70% | 58.83% | ||
| 20-Day Relative Strength | 74.20% | 41.99% | 49.72% | ||
| Weighted Alpha | -18.70 | -11.04 | +52.58 | ||
| Today's Opinion | 96% Buy | 100% Sell | 56% Buy | ||
| Previous Opinion | 96% Buy | 100% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | -6.89% since 06/26/24 | +1.49% since 06/25/24 | ||
| Low | 74.86 on 08/10/22 | 5.79 on 06/27/24 | 41.01 on 06/26/24 | ||
| High | 76.01 on 08/16/22 | 6.55 on 07/02/24 | 47.26 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | -11.70% since 06/03/24 | +2.54% since 05/31/24 | ||
| Low | 74.57 on 07/21/22 | 5.79 on 06/27/24 | 41.01 on 06/26/24 | ||
| High | 76.01 on 08/16/22 | 7.51 on 06/06/24 | 48.71 on 06/04/24 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | -5.81% since 04/03/24 | -1.00% since 04/02/24 | ||
| Low | 30.85 on 05/25/22 | 5.79 on 06/27/24 | 41.01 on 06/26/24 | ||
| High | 76.01 on 08/16/22 | 7.76 on 05/20/24 | 53.70 on 05/22/24 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | -42.52% since 01/03/24 | +28.68% since 01/02/24 | ||
| Low | 23.77 on 03/15/22 | 5.30 on 03/06/24 | 33.67 on 01/05/24 | ||
| High | 76.01 on 08/16/22 | 11.73 on 01/04/24 | 53.70 on 05/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 4,482,891 | 3,591,285 | ||
| Shares Outstanding, K | 50,074 | 687,560 | 78,860 | ||
| Annual Sales | 30,830,000 | 7,134,500,000 | 4,010,000 | ||
| Annual Net Income | -236,550,000 | 64,200,000 | -214,530,000 | ||
| Last Quarter Sales | 120,000 | 2,025,030,000 | 640,000 | ||
| Last Quarter Net Income | -123,090,000 | 58,780,000 | -66,930,000 | ||
| 60-Month Beta | -0.18 | 0.49 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | 0.09 on 07/27/23 | -0.93 on 05/09/24 | ||
| Latest Earnings Date | 08/08/22 | 07/25/24 | 08/13/24 | ||
| Most Recent Dividend | N/A | 0.370 on 06/03/21 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/03/21 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||